Andrew Oxtoby serves as Executive at Aimmune Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Oxtoby has executed 9 insider transactions totaling $44.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 13, 2020 involved selling 20,250 shares valued at $698.6K.
Andrew Oxtoby currently holds 26,595 shares of Aimmune Therapeutics, Inc. (AIMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Oxtoby has been a net buyer of AIMT stock. They have purchased $44.3K and sold $0 worth of shares.
Andrew Oxtoby's most recent insider trade was on Oct 13, 2020, when they sold 20,250 shares at $34.50 per share.
Get notified when new Form 4 filings are submitted
| 6,345 |
| $34.50 |
| Discretionary |
| Sep 15, 2020 | AIMT | $28.8K | Payment | 840 | $34.25 | Discretionary |
| May 10, 2020 | AIMT | $0 | Award | 2,420 | $N/A | Discretionary |
| Mar 13, 2020 | AIMT | $44.3K | Purchase | 3,000 | $14.76 | Discretionary |
| Feb 28, 2020 | AIMT | $0 | Award | 11,250 | $N/A | Discretionary |
| Feb 28, 2020 | AIMT | $0 | Award | 11,250 | $N/A | Discretionary |
| Jan 22, 2020 | AIMT | $41.0K | Payment | 1,235 | $33.23 | Discretionary |
| Jan 22, 2019 | AIMT | $0 | Award | 12,000 | $N/A | Discretionary |